RECURRENT HEPATOCELLULAR CARCINOMA
Clinical trials for RECURRENT HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RECURRENT HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for recurrent liver cancer after transplant?
Disease control TerminatedThis study tested the drug lenvatinib in people whose liver cancer returned after a liver transplant. The goal was to see if the drug could shrink or slow the cancer. Only 3 people took part before the study was stopped early. The drug works by blocking enzymes that help cancer c…
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Emory University • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
Proton beam therapy tested for liver cancer control
Disease control TerminatedThis study tested a precise type of proton radiation for people with liver cancer. The goal was to see if it could control the cancer while limiting harm to the liver. Nine adults with early-stage or recurrent liver cancer took part. The trial was stopped early, but the results h…
Matched conditions: RECURRENT HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 11, 2026 20:49 UTC